Search filters

List of works by Nicolino Ruperto

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

scientific article published on April 2011

2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects

scientific article published on 01 November 2017

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatri

scientific article published on 6 April 2017

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology

scientific article published on May 2017

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology

scientific article published on 6 April 2017

2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatri

scientific article published on May 2017

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll

scientific article published on 28 August 2015

A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus

scientific article

A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results

scientific article published in February 2005

A randomized, double-blind, placebo-controlled trial of paracetamol and ketoprofren lysine salt for pain control in children with pharyngotonsillitis cared by family pediatricians

scientific article

A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities

scientific article

A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry

scientific article published on 18 October 2017

Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis

scientific article published in July 2010

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

scientific article

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis

scientific article

Agreement between multi-dimensional and renal-specific response criteria in patients with juvenile systemic lupus erythematosus and renal disease

scientific article published on May 2010

Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis

scientific article

American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis.

scientific article published in July 2011

An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor-associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome

scientific article published on 01 November 2018

An international registry on autoinflammatory diseases: the Eurofever experience

scientific article

Classification Criteria and Diagnostic Tests for Vasculitides ⬇️

scientific article published on 01 August 2012

Classification criteria for autoinflammatory recurrent fevers

scientific article published on 24 April 2019

Clinical assessment in juvenile dermatomyositis

scientific article published on May 2006

Clinical trials in children and adolescents with systemic lupus erythematosus: methodological aspects, regulatory landscape and future opportunities

scientific article published on 19 September 2018

Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis

scientific article published on January 1, 2011

Criteria to define response to therapy in paediatric rheumatic diseases

scientific article

Current evidence for the medical treatments of systemic juvenile idiopathic arthritis

scientific article published on 17 September 2014

Current medical treatments for juvenile idiopathic arthritis ⬇️

scientific article published on October 10, 2011

Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

scientific article published on 11 August 2017

Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritis

scientific article published in September 2011

Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept

scientific article published on 20 December 2016

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation

scientific article

Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy

scientific article published on 23 January 2017

Efficacy and Safety of Canakinumab in sJIA Patients with and without Fever at Baseline: Results from an Open-label, Active Treatment Extension Study

scientific article published on 10 July 2020

Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label 2-Year Extension of a Phase 3 Trial

scientific article published on 20 September 2020

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study

scientific article

Emerging drugs to treat juvenile idiopathic arthritis ⬇️

scientific article published on April 30, 2011

Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop

scientific article published on 15 February 2019

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial

Ethics bureaucracy: a significant hurdle for collaborative follow-up of drug effectiveness in rare childhood diseases

scientific article published on 22 February 2012

Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers

scientific article published on 30 January 2015

Extrapolation or controlled trials in paediatrics: the current dilemma

scientific article published on 26 August 2017

Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis

scientific article published on 23 July 2020

Growth and Puberty in Juvenile Dermatomyositis: A Longitudinal Cohort Study

scientific article published on 01 February 2020

Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage

scientific article published in June 2004

Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study

scientific article published in April 2009

Impact of the European paediatric legislation in paediatric rheumatology: past, present and future

scientific article published on 20 August 2013

International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies

scientific article published on 01 September 2005

International research networks in pediatric rheumatology: the PRINTO perspective

scientific article published in September 2004

Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial.

scientific article published on 2 February 2017

Is it time to move to active comparator trials in juvenile idiopathic arthritis?: a review of current study designs

scientific article

Juvenile idiopathic arthritis and malignancy

scientific article published on June 2014

Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate

scientific article published on 01 July 2020

Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

scientific article

Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years

scientific article published on 19 June 2015

Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients

scientific article

Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-

scientific article

Measuring Disease Damage and its Severity in Childhood-Onset Systemic Lupus Erythematosus

scientific article published on 6 February 2018

Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial

scientific article

Network in pediatric rheumatology: the example of the Pediatric Rheumatology International Trials Organization

scientific article published on August 2008

Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO) ⬇️

scientific article published on February 12, 2011

Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis

scientific article published on 01 March 2019

Outcome in juvenile onset systemic lupus erythematosus

scientific article

Parent and child acceptable symptom state in juvenile idiopathic arthritis

scientific article published in February 2012

Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry

scientific article published on 15 November 2015

Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study

scientific article published on 28 December 2017

Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries

scientific article published on 17 September 2014

Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries ⬇️

scientific article published on 27 December 2018

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

scientific article

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

scientific article

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

scientific article

Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

scientific article

Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: The pediatric rheumatology international trials organization multinational quality of life cohort study

article

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis

scientific article published on December 2012

Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab

scientific article published on 28 August 2015

Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative

scientific article published on 11 October 2017

Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis

scientific article published on 10 September 2019

Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score

scientific article published in July 2012

Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children

scientific article published on 5 March 2013

Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

scientific article published on 22 July 2020

Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

scientific article published on 14 September 2011

Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial

scientific article published on 15 May 2017

Tapering Canakinumab Monotherapy in Patients with Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results from an Open-label, Randomized Phase IIIb/IV Study

scientific article published on 11 August 2020

The Algerian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Argentinian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Brazilian Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The British English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Bulgarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Canadian English and French versions of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Chilean Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Croatian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Czech version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Danish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Estonian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Georgian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Greek version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Hebrew version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Latvian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Libyan Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Lithuanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Mexican Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients

The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis

scientific article

The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis

scientific article published on March 2007

The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the definition of improve

article

The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry

scientific article

The Polish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Romanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Serbian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Slovak version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Slovene version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Thai version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article published on 7 April 2018

The Ukrainian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

scientific article

The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial

scientific article published on 7 September 2010

The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry

scientific article published on 30 April 2018

The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry

scientific article published on 27 March 2018

Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study

scientific article published on 25 October 2012

Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

scientific article

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

scientific article

Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis

scientific article

Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes

scientific article

Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus

scientific article

Paulina is supported by:

About Paulina

Help